Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency

1 Aug 2000

Abstract excerpt

OBJECTIVE: To assess the effectiveness of free beta-hCG, pregnancy-associated plasma protein A, and nuchal translucency in a prospective first-trimester prenatal screening study for Down syndrome and trisomy 18. METHODS: Risks were calculated for Down syndrome and trisomy 18 based on maternal age and biochemistry only (n = 10,251), nuchal translucency only (n = 5809), and the combination of nuchal translucency...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down syndrome and intellectual disability research
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10908764
DOI: 10.1016/s0029-7844(00)00881-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencyPMID 10908764Read ↗

First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencySemantic proximity Read ↗

First trimester fetal nuchal translucencySemantic proximity Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

Effect of first‐trimester nuchal translucency on second‐trimester maternal serum biochemical screening for Down's syndromeSemantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screeningSemantic proximity Read ↗

Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk womenSemantic proximity Read ↗

Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Semantic proximity Read ↗

First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.Semantic proximity Read ↗

First-Trimester Screening for Trisomies 21 and 18Semantic proximity Read ↗

Nearly a third of abnormalities found after first‐trimester screening are different than expected:10‐year experience from a single centerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.